Sales Contact
T: +33 1 4770 3024
Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview


> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [932 EMAT Reports], which includes:


Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.


The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.


The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.


Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
19/12/2019 Getinge Applikon Biotechnology Netherlands Medical Equipment ** 97683
30/10/2019 KOS Charleston Holding Germany Care Home *** 97631
29/10/2019 Dentressangle Marle International France Medical Implants or Prostheses Manufacturers ** 96851
26/09/2019 Groupe Léa Nature (Pharmaconcept Communication Developpement) Boho Green (Bo.Ho) France Personal Products * 96391
06/08/2019 Sofina (Société Financière de Transports et d'Entreprises Industrielles) Drylock Technologies Belgium Personal Products, Baby and Childcare Products * 96011
05/08/2019 Cellink Cytena Germany Medical Equipment ** 95828
26/07/2019 Private Group Led by 3i Infrastructure Ionisos Ain Medical Equipment * 96547
11/07/2019 Colgate-Palmolive Laboratories Filorga Cosmetiques Paris Personal Products ** 95502
25/06/2019 Private Group Led By FFP Financiere Acteon Gironde Medical Equipment * 97447
07/06/2019 Private group led by Advent International Vitaldent Spain Specialist Care ** 97715
28/01/2019 Zebra Technologies Temptime United States Medical Equipment ** 97005
25/01/2019 Emami Creme 21 Germany Personal Products * 94338
21/01/2019 Private group led by Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partners (ActoMezz) Bioclinic (SELAS BIO-CLINIC) Hauts-De-Seine Medical Diagnostic Laboratory * 94685
11/01/2019 L'Occitane International Elemis England Personal Products *** 94357
04/01/2019 Health and Happiness (H&H) International Holdings Aurelia Probiotic Skincare United Kingdom Personal Products ** 94484
19/12/2018 ATS Automation Tooling Systems Comecer Italy Medical Equipment ** 92686
26/11/2018 AddLife BIOMEDICA Medizinprodukte Austria Medical Equipment ** 92884
20/11/2018 Private Group led by CBPE Capital Blatchford United Kingdom Medical Implants or Prostheses Manufacturers ** 97272
08/11/2018 Aphria CC Pharma Germany Drugs Retailers, Pharmaceuticals ** 92067
04/09/2018 Cattleya Finance Parfums Caron Paris Personal Products ** 93591
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report